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Background. Huntington’s disease (HD) is a genetic disorder expressed by a degeneration of the basal ganglia inter alia
accompanied with dopaminergic alterations. These dopaminergic alterations are related to genetic factors i.e., CAG-repeat
expansion. The error (related) negativity (Ne/ERN), a cognitive event-related potential related to performance monitoring, is
generated in the anterior cingulate cortex (ACC) and supposed to depend on the dopaminergic system. The Ne is reduced in
Parkinson’s Disease (PD). Due to a dopaminergic deficit in HD, a reduction of the Ne is also likely. Furthermore it is assumed
that movement dysfunction emerges as a consequence of dysfunctional error-feedback processing. Since dopaminergic
alterations are related to the CAG-repeat, a Ne reduction may furthermore also be related to the genetic disease load.
Methodology/Principle Findings. We assessed the error negativity (Ne) in a speeded reaction task under consideration of
the underlying genetic abnormalities. HD patients showed a specific reduction in the Ne, which suggests impaired error
processing in these patients. Furthermore, the Ne was closely related to CAG-repeat expansion. Conclusions/Significance.
The reduction of the Ne is likely to be an effect of the dopaminergic pathology. The result resembles findings in Parkinson’s
Disease. As such the Ne might be a measure for the integrity of striatal dopaminergic output function. The relation to the CAG-
repeat expansion indicates that the Ne could serve as a gene-associated ‘‘cognitive’’ biomarker in HD.
Citation: Beste C, Saft C, Andrich J, Gold R, Falkenstein M (2006) Error Processing in Huntington’s Disease. PLoS ONE 1(1): e86. doi:10.1371/
journal.pone.0000086
INTRODUCTION
Huntington’s disease (HD) is an autosomal dominant, monogentic
neurological disorder causing a degeneration of the neostriatum.
The disease is genetically expressed by an extension of the CAG-
repeat length at the 4
th chromosome [1] encoding a large protein,
the ‘‘huntingtin’’. This protein accumulates and causes apoptotic
striatal neuronal death [2]. The most obvious sign of HD is chorea:
rapid, arrhythmic and complex involuntary movements, which are
supposed to be an effect of dysfunctional error-feedback processing
[3]. Besides these motor symptoms, psychiatric and cognitive
deterioration appear, finally associated with dementia [4]. HD is
accompanied by alterations in the dopaminergic system with
a reduction in D1 and D2 receptor density [5,6]. It is shown that
the decreased striatal dopamine receptor content is related to CAG-
repeatlength[7,8].Also animalstudies show a closerelation of CAG
repeat expansion and dopaminergic alterations [9]. Yet besides
dopaminergic alterations, other neurotransmitter systems are also
affected [10] and neuroanatomical degeneration is wide spread [11].
The dopaminergic system itself is involved in many cognitive
processes. One such process most likely depending on the
dopamine system is the processing of errors and hence
performance monitoring. A means to assess error-related processes
is via an event-related potential (ERP), called error negativity (Ne)
[12] or error-related negativity (ERN) [13]. A major source of the
Ne is located in the medial frontal cortex, especially the anterior
cingulate cortex (ACC) [14–16]. The Ne is classically interpreted
as the detection of a mismatch or conflict between response
representations [12,13,16,17]. Another theory [18] assumes a more
general functional significance of the Ne. According to this
‘‘reinforcement learning hypothesis’’ the midbrain dopamine system
(DA-system) supervises and evaluates evolving events, such as
responses. If an event is not as expected (e.g. an incorrect
response), the DA-system sends an error signal to the ACC which
in turn elicits the Ne. There is converging evidence that the Ne is
in fact dependent on the dopaminergic system [16,18–22]. In
particular, the Ne is reduced in the most common basal ganglia
disease, Parkinson’s disease (PD) [22], but also a null result is
reported [23]. Further, the Ne was found to be reduced in patients
with focal basal ganglia lesions [24].
The goal of the present study is to investigate whether patients
with HD also show alterations of the Ne as shown in PD.
Although, the fundamental deficit is different in the two diseases,
i.e. in PD the primary deficit is a reduction of DA-producing cells
in the substantia nigra, hence leading to a presynaptic deficit. In
HD striatal cells are affected, hence leading to a (post)synaptic
deficit. Finally, both Parkinson’s and Huntington’s disease
compromise striatal output function. If the Ne depends on an
output signal from the basal ganglia to the ACC, this should also
cause a reduction of the Ne in HD. Such a finding would
strengthen the evidence that the Ne is related to the integrity of the
dopaminergic striatal output and may serve as a measure of this
integrity, maybe even define a gene-associated biomarker in HD,
since dopaminergic alterations in HD are related to genetic factors
(e.g. CAG repeat expansion) [7–9].
METHODS
Participants
Eleven right-handed, unmedicated HD-patients (N=11) from 26
to 57 years of age [mean=39.81, SD=68.96] genetically
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study. A clinical description of the HD-patients is given in Table 1.
Psychiatric assessment showed that there was no manifest
depression as indicated by the Beck Depression Inventory (BDI)
[mean=6.54; SD=64.36]. Assessment using the Young Mania
Rating Scale for adults (YMRS) revealed no mania [mean=4.63;
SD=63.50]. Cognitive screening for dementia using the Mini
Mental Status Examination (MMSE) revealed no dementia
[mean=27.09; SD=62.11]. Furthermore 12 healthy controls
were from 26 to 57 years of age were recruited (mean=38.12;
SD=67.56). The same psychiatric assessment using the BDI
revealed no depression [mean=1.83; SD=61.46] or any mania
[mean=1.16; SD=60.83] as revealed by the YMRS. Both
groups had a comparable educational background. All participants
gave written informed consent. The study was approved by the
ethics committee of the University of Bochum.
Task
To measure error-related processing we used a ‘‘Flanker Task’’ [26]
which reliably yields a high percentage of errors. This task was
similar to one of the three tasks used in the cited PD-study [22]. In
the present task vertically arranged visual stimuli were presented.
The target-stimulus (arrowhead or circle) was presented in the
center with the arrowhead pointing to the right or left. The central
stimuli were flanked by two vertically adjacent arrowheads which
pointed in the same (compatible) or opposite (incompatible)
direction as the target. The flankers preceded the target by 100 ms
to maximize premature responding to the flankers, which would
result in errors in the incompatible and Nogo condition. The
target was displayed for 300 ms. The response-stimulus interval
was 1600 ms. Flankers and target were switched off simultaneous-
ly. Time pressure was administered by asking the subjects to
respond within 550 ms. In trials with reaction times exceeding this
deadline a feedback stimulus (1000 Hz, 60 dB SPL) was given
1200 ms after the response; this stimulus had to be avoided by the
subjects. Four blocks of 105 stimuli each were presented in this
task. Compatible (60%) and incompatible stimuli (20%) and Nogo-
stimuli (circle) (20%) were presented randomly. The subjects had
to react with the thumb depending on the direction of the central
arrowhead and to refrain from responding to circles. The Nogo
trial data were not further evaluated within the present study,
which focused on error processing and not on inhibition.
EEG recording and analysis
During the task the EEG was recorded from 32 electrodes (Ag/
AgCl) (Fpz, Fp1, Fp2, Fz, F3, F4, F7, F8, FCz, FC3, FC4, FC5,
FC6, Cz, C3, C4, C7, C8, Pz, P3, P4, P7, P8, Oz, O1, O2, M1,
M2), two lateral and four vertical EOG electrodes (sampling rate:
500 Hz). Cz was used as primary reference. The filter bandwidth
was from DC to 80 Hz. Impedances were kept below 8 kV. The
EEG was digitally filtered using a 0.10 Hz high-pass and 20 Hz
low-pass filter. From the EEG response-locked ERPs were
computed, beginning 400 ms before and ending 700 ms after
the correct or incorrect response. After this, eye movement
artifacts were corrected with the Gratton-Coles-Algorithm using
the EOG data [27], followed by a baseline correction (2200 ms -
0 ms [i.e. response]). Remaining artifacts were rejected using an
amplitude criterion of 680 mV followed by re-referencing all data
to linked mastoids. The Nogo trial data were not further
evaluated. The amplitude of the Ne in error trials and of the
CRN in the correct trials was measured relative to the peak of the
positivity, which precedes both components [26,28,29].
Statistics
Peak-to-peak amplitudes were subjected to a repeated-measures
ANOVA with electrode (Fz, Fcz, Cz) and correctness (right/false)
as within-subject factors and group (HD, controls) as between-
subject factor. The degrees of freedom were adjusted using the
Greenhouse-Geisser-Correction when appropriate. In addition,
separate univariate ANOVAs of the post-response negativities
after false (i.e. the Ne/ERN) were conducted at electrodes Fz, FCz
and Cz with the between-subject factor group. For these analyses
Bonferroni-corrections were applied. Tests of normal distribution
using the Kolmogorov-Smirnov Test revealed that each variable
included to the ANOVAs was normal distributed (all z,0.883;
p..205; one-tailed). Because of higher test-power, one-tailed tests
were used. As a measure of variability the standard deviation (SD)
together with the mean is given.
RESULTS
Behavioral data
The analysis of the reaction time (RT) revealed that the HD-group
reacted more slowly than the control group in correct responses (c-
RT) [HD: 420.74 ms613.96] [controls: 324.19 ms613.36]
(F(1,219=24.94; p,.001). The same was apparent for the error
responses (f-RT) [HD: 330.34 ms660.66] [controls: 259.12 ms6
35.59] (F(1,12)=12.04; p=.002). Both groups did not differ with
respect to the frequency of errors [HD: 20.7269.50] [controls:
25.33610.25] (F(1,21)=1.24; p=.278). RTs of correct responses
after an error was committed (post-RT) are generally prolonged,
which reflects the behavioral adaptation after an error. Therefore
we subjected the mean reaction time of all correct responses and
those after an error as within-subject factor to a repeated measure
ANOVA with group as between-subject factor. Post-RTs
[402.41 ms616.27], were significantly longer than c-RTs
[372.46 ms69.66] (F(1,21)=7.26; p=.014); no interaction with
the factor group (F(1,21)=1.37; p=.255) was obtained.
Electrophysiological data
The potentials of the Ne and the CRN are given in Figure 1. The
response-related negative potential differed significantly between
Table 1. Clinical description of the HD-patients.
......................................................................
Patients CAG
UHDRS
(motor)
UHDRS
(cognitive) TFC IS
1 52 42 180 10 70
24 0 9 3 6 01 2 9 5
3 47 32 137 12 80
4 41 12 143 13 90
5 43 11 201 12 90
6 50 27 149 12 90
7 51 28 164 12 90
8 41 10 215 13 100
9 49 25 191 12 90
10 44 44 149 12 80
11 50 27 211 12 90
Mean (SD) 46.18(4.49) 24.27(12.47) 190.90(62.63) 12(0.77) 87.72(8.17)
The table depicts values for CAG-repeat, UHDRS motor score (UHDRS (motor))
[25], UHDRS cognitive score (UHDRS (cognitive)), total functional capacity scale
(TFC) and independence scale (IS) for each single patient and the whole HD-
group with mean and standard deviation (SD).
doi:10.1371/journal.pone.0000086.t001
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PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e86the electrodes (F(2,42)=41.61; p,.001). Response-related nega-
tivities were larger at Fz [26.49 mV] and FCz [27.05 mV]
compared to Cz [23.62 mV] (p,.001). Fz and FCz did not differ
from each other (p=.331). Furthermore the groups differed with
respect to the activity at the different electrodes, as reflected in
a group by electrode interaction (F(2,42)=5.75; p=.006). As
expected, the brain potentials strongly differed between correct
and error responses (F(1,21)=37.70; p,.001). This effect differed
between groups, as reflected in a group by correctness interaction
(F(1,21)=5.56; p=.028). A subsequent simple-effects analysis
revealed that the factor group was significant for error responses
(F(1,21)=8.39; p=.009) but not for correct responses (F(1,21)=
0.009; p=.925). The separate ANOVA for the Ne (i.e. error
responses) at electrode FCz (where the Ne is usually maximum)
showed that the Ne was smaller in HDs [28.6163.51] than in
controls [212.7565.27] (F(1,21)=4.78; p=.040) (Fig. 1 top).
Similar but even larger effects were seen at Fz [HD: 26.7062.20]
[controls: 211.5664.10] (F(1,21)=12.19; p=.002) and Cz [HD:
23.3460.90] [controls: 25.4861.80] (F(1,219=12.51; p=.002)
(Fig. 1 bottom). To check the possibility that the reduction of the
Ne in HD patients is due to a larger latency variance we measured
the Ne latency in single low-pass filtered error trials [22]. The
intrasubject variances of the negative peak latencies for the
electrode Fz and FCz were subjected into a repeated measures
ANOVA with the between-subject factor group. The intrasubject
variances of the negative peak latencies did not differ neither
between the electrodes (F(1,21)=0.005; p=.943) nor when the
factor group was taken into account, too (F(1,21)=1.008;
p=.327). The main effect group showed that both groups also
did not differ with respect to intrasubject variances (F(1,21)=2.88;
p=.104). The most well-known ERP is the P300. Analyzing this
component at electrode Pz across the time window from 200 till
500 ms revealed no difference between the groups [controls:
9.2260.93] [HD: 7.1560.97] (F(1,21)=1.60; p=.219).
In a second step we analyzed the relation of genetic factors to the
Ne. For this purpose we used the CAG-index, i.e. the number of
triplets in excess (CAGn – 35.5), multiplied by the age of the patient.
The CAG-index is an expression of genetic disease load normalized
to each individual [2,30]. The mean CAG-index was 403.81
(SD=154.34). For correlational purposes we used electrode Fz
(which showed the maximum group effect on Ne amplitude) and
FCz (the usual maximum of the Ne). Pearson-correlation revealed
that the CAG-index was correlated with the peak-to-peak amplitude
of the Ne at Fz (r=.872,R
2=0.75;p,.001) (Figure 2).
A similar but smaller correlation was found for FCz (r=.603,
R
2=0.36; p=.025). However, one can argue that this correlation
might be driven by two outliers, but a further analysis excluding
these outliers also showed a significant relation of the Ne at Fz
(r=.645, R
2=0.40; p=.030) and FCz (r=.371, R
2=0.13;
p=.045). The Ne is known to show age-dependent variations
[22], which might be critical when using the age of the patient in
the calculation of the CAG-index. However, the repeat itself was
correlated to the Ne at Fz (r=.663, R
2=0.43; p=.013) and FCz
(r=.541, R
2=0.29; p=.043) indicating that ‘‘age’’ is not the
driving factor in this correlation. This is supported by the fact
that even ‘‘age’’ itsself was uncorrelated with Ne at Fz (r=.050,
R
2=0.25; p=.442) and FCz (r=2.124, R
2=0.14; p=.358).
Furthermore it could be argued that the Ne reflects the
progression of disease and only to a lesser extend the genetic
processes. To meet this objection we calculated the correlation of
the Ne with the time span since motor age of onset, as an estimate
of disease progression. It can be seen that this factor was not
related to the Ne at Fz (r=.379, R
2=0.13; p=.125) and FCz
(r=2.099, R
2=0.08; p=386).
Besides CAG-repeat length, parental age of onset [31,32] as
well as paternal vs. maternal transmission [31] is of strong
influence in and presumably reflects additional genetic and/or
environmental influences [33]. Therefore we subjected CAG-
index, parental age of onset as well as paternal vs. maternal
transmission as independent variables to a stepwise linear
regression analysis with the Ne/ERN as dependent variable.
The results show that the incorporation of these additional
parameters did not increase the amount of explained variance,
as shown by the partial correlations (parental age of onset:
r=.605; p=.112) (paternal vs. maternal transmission: r=2.063;
p=.882).
DISCUSSION
In this study we examined an ERP related to error-processing (Ne)
likely dependent on the dopaminergic system in HD and its
relation to genetic factors. Deficits in this cognitive function are
assumed to play a major role in the emergence of motor symptoms
in HD [3]. We showed that (i) the Ne was reduced in HD
Figure 1. Event-related potentials of the Ne/ERN and CRN. The Ne/
ERN (false responses) and CRN (correct responses) for HD and controls
at electrode FCz (top) and at Fz (bottom). The x-axis denotes time in
milliseconds (ms). The y-axis denotes voltage in mV. The bar plots
denote significant differences in the peak-to-peak amplitude of the Ne/
ERN between the groups for the electrodes FCz (left) and Fz (right).
doi:10.1371/journal.pone.0000086.g001
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specific for the error trials (i.e. for the Ne) and related to genetics.
The behavioral data indicated that both groups committed
a comparable amount of errors. Thus the group differences in the
ERP are unbiased by the frequency of errors. Furthermore the
HD group showed no psychiatric pathology (e.g. depression),
which might also have influenced the results [34]. The behavioral
data of the present study suggest that the HD patients are able to
perform behavioral adaptation; in spite they have a reduced Ne.
This is in line with the finding that healthy old subjects usually
show a larger post-error slowing than young controls, despite
a clear reduction of their Ne [22], which either suggests that the
process reflected in the Ne is not driving the posterror slowing, or
that it operates adequately also in the patients, even when its
strength is reduced.
The pattern of results, namely a reduced Ne but unaffected
CRN closely resembles findings with Parkinson’ disease [22]. In
those patients the Ne, but not the CRN (and the Pe [35]) were
reduced compared to healthy control subjects. This strongly
suggests a similar mechanism underlying the Ne decrease in
Parkinson’s and Huntington’s disease. The reduction in the Ne in
HD can be explained by the alterations in the dopaminergic
system, which is prominent in HD [5,6], because the Ne and
hence error-processing is determined by the dopaminergic system
as stated by other findings in psychiatric and neurological diseases
[16,18–22,36]. The importance of the dopaminergic deficit is
underlined by the finding that the P300 did not differ between the
groups, which has consistently been shown to be unrelated to the
dopaminergic system [37]. As already mentioned in the in-
troduction, the pathophysiology in Parkinson’s and Huntington’s
disease is different: in PD the primary alteration is a depletion of
dopamine, i.e. a presynaptic dysfunction. In contrast, in HD, the
deficit lies in the striatal cells themselves. It is well documented in
HD that underlying genetic factors (i.e. CAG repeat length) are
related to dopaminergic alterations at the receptor level [7–9], i.e.
a strong reduction of DA receptor density in the striatum. Hence
we assume that the most likely common cause of the Ne reduction
in PD and HD is an impaired functioning of striatal DA system,
either via a presynaptic DA depletion (in PD) or a postsynaptic
(receptor) deficit (in HD). As such the Ne migth serve as an easy
deriveable measure of the integrity of the dopaminergic striatial
output function. The fact that the Ne was related to the CAG
repeat mutation, which is in turn related to the receptor density/
integrity [7–9], further supports the dependence of the Ne on
striatal DA system (receptor) functioning. This interpretation is
supported by older findings in HD in which there was no change
in the levels of free-available dopamine [38,39] that could have
influenced the results. Furthermore the findings of an altered Ne in
ADHD [19] and the effects of alcohol consumption [18,21] are
also in line with our interpretation, because ADHD is known to
show alterations at the receptor level and the effects of alcohol are
mediated at this level, too. However, besides the fact that striatal
cells are affected in HD, which might lead to the reduction of the
Ne, research indicates that also the functioning of the ACC itself is
altered [40,41]. Since the ACC is known to be a source of the Ne,
the reduction of the Ne could also be due to dysfunction in the
ACC. Although the precise neuroanatomical location underlying
the Ne-reduction is uncertain it is likely that the dopaminergic
deficit is the driving force for the Ne-alteration in HD. Irrespective
of anatomical location (striatum or ACC), the dopamine system
(receptor) reduction seems to be of importance.
As stated above we found a correlation of the Ne with the
underlying genetic alteration in HD suggesting for a relationship of
genes and cognition. Since the CAG-index is age-related, it might
be argued that the correlation simply reflect the reduction of the
Ne with advanced age [22]. However, even when we used the
CAG-repeat (which is independent of age), the correlation
remained significant. Also, we found no significant correlation
between the age of the subjects and Ne amplitude. The correlation
with the Ne amplitude can also not be attributed to be biased due
to the progression of disease, since this parameter was not related
to the Ne. This strongly suggests that age or disease progression
per se cannot explain the high correlation found in our study. As
such the relation indicates that the Ne might be used as a gene-
associated cognitive biomarker in HD. We assume that this is
possible in this case, because a monogenetic factor (CAG-repeat)
influences the integrity of the dopaminergic (receptor) system in
the basal ganglia. This in turn influences error processing
measured by the Ne. The dopaminergic alteration serves as
a mediator between genetic and cognitive processes. Generalizing
the current results of the genetic relation of the Ne it may be
hypothesized that any cognitive process can be related to genetic
factors, if it relies on predominantly one neurofunctional system
with this system prevailingly being influenced by genetics.
However, we cannot completely rule out that changes in other
neurotransmitter systems [10] or the wide spread neuropathology
[11] also have an influence, but because of the accordance of these
results with results in Parkinson’s disease and the relation to the
genetic factors, we think that the dopaminergic pathology is most
important. In similar vein, the limited sample size may also
possibly seem critical.
Perspectives
An important practical consequence from the results is that
a simple electrophysiological measure as the Ne might be useful to
evaluate dopamine (receptor) functioning in the striatum, or the
effects of pharmacological treatment [42,43]. Since we were not
able to include a direct measure of the dopamine receptor integrity
(e.g. via PET scans) this may seem somewhat speculative. Hence
we think that electrophysiological techniques (e.g. ERPs) can have
useful applications in interdisciplinary neuroscientific research.
Based upon the current results further research should focus on the
presymptomatic stage to disentangle possible early ‘‘cognitive
biomarkers’’ that might lead to a better understanding of the
processes taking place in this phase and might have useful clinical
Figure 2. The Relation of the Ne peak-to-peak amplitude at Fz and
CAG-index. This figure shows a linear relation of the Ne peak-to-peak
amplitude at electrode Fz with the CAG-index, derived via (CAGn – 35.5)
6‘‘age of the patient’’ [see: 2,30].
doi:10.1371/journal.pone.0000086.g002
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relation to other biomarkers in HD [44] should be evaluated.
Conclusions
In the current study we accounted for a reduction of a cognitive
event-related potential (i.e. Ne) in HD, which was related to the
underlying genetic alteration. Thus the Ne may be treated as an
easy derivable gene-associated cognitive biomarker in HD.
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